Serum thyroid hormone concentrations were measured before and during 10 days' treatment with atenolol (200 mg/day), acebutolol (400 mg/day), oxprenolol (160 mg/day) and propranolol (160 mg/day) in 24 hyperthyroid patients. During propranolol treatment serum triiodothyronine (T3) concentrations fell significantly (P < 0 05) but there was no change in thyroid hormone concentrations in the other groups although all patients reported a symptomatic improvement.
Introduction
Beta-adrenoreceptor blocking drugs are widely used in the treatment of hyperthyroidism. Pro- pranolol causes a fall in serum triiodothyronine (T3) concentrations in hyperthyroid patients, probably via an action on the peripheral conversion of thyroxine (T4) to T3 and reverse T3 (rT,) (Lotti et al., 1977; Kallner, Ljunggren and Tryselius, 1978; Feely et al., 1979) . The action of 3-adrenoreceptor blocking agents other than propranolol on circulating thyroid hormones in hyperthyroidism has not been widely studied, although the present authors have described the lack of effect of those drugs possessing the subsidiary property of partial agonist activity (ISA) (Jones, John and Jones, 1980 There was no significant change in thyroid hormone levels in the other groups (Fig. 2) 
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Discussion
Propranolol caused a significant (P < 0-05) and sustained fall in serum T3 concentrations to approximately 75% of pre-treatment values while atenolol, acebutolol and oxprenolol had no effect on circulating thyroid hormones. The mechanism by which propranolol exerts this action is unclear. It differs from the other drugs studied in that neither is it cardioselective nor does it have ISA (Fig. 3) . The subsidiary property of ISA cannot explain the lack of effect of acebutolol and oxprenolol since atenolol, which does not possess ISA, also had no effect. It is possible that other non-selective Padrenoreceptor blocking drugs without ISA could lower serum T3 concentrations in the same way as propranolol. The other subsidiary property of membrane stabilizing activity (MSA) must also be considered when attempting to explain the action of propranolol on serum T3 levels. It has been suggested from a study of euthyroid and hypothyroid subjects receiving T4 that this effect of propranolol is related to its MSA (Heyma et al., 1980) . In the present study, however, neither acebutolol nor oxprenolol lowered serum T3 concentrations and, although these drugs are less effective than propranolol as membrane stabilizing agents, both as local anaesthetics and in their action on intracellular cardiac potentials (Vaughan-Williams and Papp, 1970; Basil et al., 1973) , a fall would have been expected if the presence of MSA was important.
No clinical advantage was found in the patients' response to propranolol when compared with the other 3-adrenoreceptor blocking drugs. Despite initial concern over the use of 3-adrenoreceptor blocking agents with ISA in the treatment of hyperthyroidism (Turner, 1974) , this finding is supported by the results of recent studies comparing propranolol with various classes of cardioselective f-adrenoreceptor blocking agents (Nelson and McDevitt, 1975; Murchison et al., 1976; Nilsson et al., 1979; Murchison, How and Bewsher, 1979 
